These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7893871)

  • 1. Invasive otitis externa due to Aspergillus species: case report and review.
    Gordon G; Giddings NA
    Clin Infect Dis; 1994 Nov; 19(5):866-70. PubMed ID: 7893871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient.
    Finer G; Greenberg D; Leibovitz E; Leiberman A; Shelef I; Kapelushnik J
    Scand J Infect Dis; 2002; 34(3):227-9. PubMed ID: 12030404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.
    Pichon M; Joly V; Argy N; Houze S; Bretagne S; Alanio A; Wassef M; Verillaud B; Yazdanpanah Y
    Infection; 2020 Apr; 48(2):193-203. PubMed ID: 32036556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant otitis externa due to Aspergillus niger.
    Bellini C; Antonini P; Ermanni S; Dolina M; Passega E; Bernasconi E
    Scand J Infect Dis; 2003; 35(4):284-8. PubMed ID: 12839164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fungal otitis in Libreville. Study of 83 cases].
    Kombila M; Gomez de Diaz M; de Bièvre C; Crepet G; Debrie JC; Belembaogo E; Richard-Lenoble D
    Bull Soc Pathol Exot Filiales; 1989; 82(2):201-7. PubMed ID: 2743526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive external otitis caused by Aspergillus.
    Phillips P; Bryce G; Shepherd J; Mintz D
    Rev Infect Dis; 1990; 12(2):277-81. PubMed ID: 2184497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septic arthritis of the temporomandibular joint caused by Aspergillus flavus infection as a complication of otitis externa.
    Varghese L; Chacko R; Varghese GM; Job A
    Ear Nose Throat J; 2015 Mar; 94(3):E24-6. PubMed ID: 25738723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical invasive external otitis from Aspergillus.
    Bickley LS; Betts RF; Parkins CW
    Arch Otolaryngol Head Neck Surg; 1988 Sep; 114(9):1024-8. PubMed ID: 3408569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical presentations of malignant otitis externa.
    Vourexakis Z; Kos MI; Guyot JP
    J Laryngol Otol; 2010 Nov; 124(11):1205-8. PubMed ID: 20193102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs.
    Harley WB; Dummer JS; Anderson TL; Goodman S
    Clin Infect Dis; 1995 Apr; 20(4):1052-4. PubMed ID: 7795050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus necrotizing otitis externa with temporomandibulozygomatic involvement.
    Noroy L; Pujo K; Leghzali-Moise H; Saison J
    Eur Ann Otorhinolaryngol Head Neck Dis; 2020 Mar; 137(2):127-129. PubMed ID: 32139197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal malignant otitis externa treated with hyperbaric oxygen.
    Ling SS; Sader C
    Int J Infect Dis; 2008 Sep; 12(5):550-2. PubMed ID: 18508401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ceftazidime for malignant external otitis.
    Kimmelman CP; Lucente FE
    Ann Otol Rhinol Laryngol; 1989 Sep; 98(9):721-5. PubMed ID: 2675731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ear infections by Aspergillus].
    Doñamayor Hernández C
    An Otorrinolaringol Ibero Am; 1990; 17(5):535-44. PubMed ID: 2126916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of bilateral otomycosis associated with Aspergillus flavus and A. terreus in Taiwan.
    Kirschner R; Sun PL; Huang SL; Chen CL; Yang CP
    J Mycol Med; 2017 Sep; 27(3):412-416. PubMed ID: 28501466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bacterial otitis externa: efficacy and safety of topical treatment with an antibiotic ear drop formulation in comparison to glycerol treatment.
    Mösges R; Baues CM; Schröder T; Sahin K
    Curr Med Res Opin; 2011 Apr; 27(4):871-8. PubMed ID: 21332272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Aspergillus flavus Otitis Externa with Jugular Thrombosis.
    Moniot M; Montava M; Ranque S; Scemama U; Cassagne C; Arthur V
    Emerg Infect Dis; 2019 Apr; 25(4):830-832. PubMed ID: 30882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant otitis externa in AIDS patients: case report and review of the literature.
    Weinroth SE; Schessel D; Tuazon CU
    Ear Nose Throat J; 1994 Oct; 73(10):772-4, 777-8. PubMed ID: 7805599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.